These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 11751743)

  • 1. Sodium-lithium countertransport activity is linked to chromosome 5 in baboons.
    Hardman TC; Noble MI
    Hypertension; 2001 Dec; 38(6):E35-6. PubMed ID: 11751743
    [No Abstract]   [Full Text] [Related]  

  • 2. Sodium-lithium countertransport activity is linked to chromosome 5 in baboons.
    Kammerer CM; Cox LA; Mahaney MC; Rogers J; Shade RE
    Hypertension; 2001 Feb; 37(2 Pt 2):398-402. PubMed ID: 11230307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of SLC34A2 variation and sodium-lithium countertransport activity in humans and baboons.
    Zheng X; Kammerer CM; Cox LA; Morrison A; Turner ST; Ferrell RE
    Am J Hypertens; 2009 Mar; 22(3):288-93. PubMed ID: 19119262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E gene polymorphism and sodium-lithium countertransport activity.
    Hardman T; Noble MI
    Metabolism; 2001 Nov; 50(11):1386-8. PubMed ID: 11715937
    [No Abstract]   [Full Text] [Related]  

  • 5. Genome-wide linkage study of erythrocyte sodium-lithium countertransport.
    Morrison AC; Boerwinkle E; Turner ST; Ferrell RE
    Am J Hypertens; 2005 May; 18(5 Pt 1):653-6. PubMed ID: 15882547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythrocyte sodium-lithium countertransport and blood pressure: a genome-wide linkage study.
    Weder AB; Delgado MC; Zhu X; Gleiberman L; Kan D; Chakravarti A
    Hypertension; 2003 Mar; 41(3 Pt 2):842-6. PubMed ID: 12624006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered membrane microviscosity in essential hypertension: relationship with family history of hypertension and sodium-lithium countertransport activity.
    Carr SJ; Sikand K; Moore D; Norman RI
    J Hypertens; 1995 Jan; 13(1):139-46. PubMed ID: 7759844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model-fitting and linkage analysis of sodium-lithium countertransport.
    Hasstedt SJ; Camp NJ; Hopkins PN; Coon H; McKinney JT; Cawthon RM; Hunt SC
    Eur J Hum Genet; 2004 Dec; 12(12):1055-61. PubMed ID: 15383825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of sodium-lithium countertransport kinetics.
    Thomas TH; West IC; Rutherford PA
    Hypertension; 1996 Feb; 27(2):313-4; author reply 316. PubMed ID: 8567059
    [No Abstract]   [Full Text] [Related]  

  • 10. Measurement of sodium-lithium countertransport kinetics.
    Hardman T; Lant A
    Hypertension; 1996 Feb; 27(2):314-5; author reply 315-6. PubMed ID: 8567060
    [No Abstract]   [Full Text] [Related]  

  • 11. Measurement of sodium-lithium countertransport kinetics.
    Wierzbicki AS
    Hypertension; 1996 Feb; 27(2):315; author reply 316. PubMed ID: 8567061
    [No Abstract]   [Full Text] [Related]  

  • 12. Association between SLC20A1 and sodium-lithium countertransport.
    Zheng X; Morrison AC; Turner ST; Ferrell RE
    Am J Hypertens; 2011 Oct; 24(10):1069-72. PubMed ID: 21796222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephropathy and changes in sodium-lithium countertransport kinetics in type 2 (non-insulin-dependent) diabetes mellitus.
    Rutherford PA; Thomas TH; Taylor R; Wilkinson R
    J Hum Hypertens; 1994 Jan; 8(1):29-35. PubMed ID: 8151603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrocyte membrane cholesterol distribution in patients with untreated essential hypertension: correlation with sodium-lithium countertransport.
    Muriana FJ; Villar J; Ruíz-Gutiérrez V
    J Hypertens; 1996 Apr; 14(4):443-6. PubMed ID: 8761892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte sodium-lithium countertransport in African American women.
    Hardman TC; Wierzbicki AS
    J Hum Hypertens; 2001 Jul; 15(7):505-6. PubMed ID: 11464263
    [No Abstract]   [Full Text] [Related]  

  • 16. Sodium-lithium countertransport activity in healthy, dyslipidemic, and hypertensive individuals.
    Savopoulos CG; Hatzitolios AI; Katsiki NA; Baltatzi M; Kosmidou M; Raikos N; Mikhailidis DP; Ziakas AG; Kaiafa G; Tsesmeli N
    Angiology; 2008 Dec-2009 Jan; 59(6):727-35. PubMed ID: 18840623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-I converting enzyme (ACE) gene polymorphism and the erythrocyte sodium-lithium countertransport in hypertension.
    Delanghe J; De Buyzere M; Wuyts B; Tournoy K; Duprez D; Clement D
    J Hum Hypertens; 1997 Apr; 11(4):251-2. PubMed ID: 9185032
    [No Abstract]   [Full Text] [Related]  

  • 18. Sodium-lithium countertransport and the Gly460-->Trp alpha-adducin polymorphism in essential hypertension.
    Mead PA; Harvey JN; Rutherford PA; Leitch H; Thomas TH
    Clin Sci (Lond); 2005 Mar; 108(3):231-6. PubMed ID: 15554870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of sodium-lithium countertransport activity to markers of cardiovascular risk in normotensive subjects.
    Hardman TC; Dubrey SW; Soni S; Lant AF
    J Hum Hypertens; 1995 Jul; 9(7):589-96. PubMed ID: 7562890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher urinary albumin excretion is associated with abnormal erythrocyte Na(+)/Li(+) countertransport (SLC) in non-modulating essential hypertensives and offspring of hypertensive parents.
    Sánchez RA; Giannone C; Masnatta LD; Baglivo HP; Ramírez AJ
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S128-32. PubMed ID: 11986910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.